Century Therapeutics (IPSC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Each player has an overall Valorant rank, but there’s also a dedicated ‘Act rank’ for each act. On top of that, there’s also a concept called ‘rank rating’, which is connected to MMR.